On Appeal, Scientists Dispute Inventorship Of Cancer Treatment Patents
WASHINGTON, D.C. — In a March 25 appellee brief, the two named inventors of a patented treatment for castration resistant prostate cancer defend the rejection by a California federal judge of...To view the full article, register now.
Already a subscriber? Click here to view full article